Neumora Therapeutics, Inc. Common Stock (NMRA) NASDAQ
2.25
+0.02(+0.90%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 292.47M |
| Enterprise Value | 110.42M |
| P/E Ratio | -1.55 |
| PEG Ratio | -0.33 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.54 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.96 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -1.24 |
| Return On Equity | -1.46 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -5M |
| EBITDA | -233.37M |
| Net Income | -236.93M |
| Diluted EPS | -1.45 |
Balance Sheet
| Total Cash | 182.53M |
| Total Cash/Share | 1.12 |
| Total Debt | 477,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 5.87 |
| Book Value Per Share | 0.64 |
Price History
| 52-Week Change | 197.03 |
| 52-Week High | 3.65 |
| 52-Week Low | 0.61 |
| Moving Average 50 Days | 2.7 |
| Moving Average 200 Days | 2.16 |
Statistics
| Average Volume | 1.29M |
| Shares Outstanding | 182.04M |
| % Held by Institutions | 38.99 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
